Join Us on Facebook

Click here to request a sample

Click here to read our groundbreaking study published in the Journal of Clinical Psychiatry

In the news

The British Medical Journal reports: Does antidepressant use in youth increase risk of suicide?

This week, The British Medical Journal reported on a review of over 18,000 subjects on SSRI therapy: “In the randomised trials children say that they don’t work for them, but they increase their risk of suicide.” Read more here: Access the full study here:

Does depression contribute to aging?

“Scientists of a new study published this week in Biological Psychiatry sought to bring all this prior work together by studying the relationships between telomere length, stress, and depression.” Read more here: Depression & Aging

view more

EnLyte® is indicated for depression therapy for patients at risk of folate deficiency as determined by a licensed medical practitioner; for obstetrics patients who may be at risk of postpartum depression; and as a prescription pre-natal/post-natal vitamin for women at increased risk of having offspring with neural tube defects (NTDs), and who would benefit from advanced folate supplementation.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Daily ingestion of more than 3 grams per day of omega-3 fatty acids (ALA, EPA, and DHA) from fish oils may have potential antithrombotic activities, or effects, and may increase bleeding times. Administration of omega-3 fatty acids, including DHA, should be avoided in individuals with inherited or acquired bleeding diathesis, including those taking anticoagulants. Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 gram (1000 mg) per day.

Please see full prescribing information.